The
global Hepatitis Diagnostics
Market is
expected to reach USD 6.9 billion by 2025, according to a new report by Grand
View Research, Inc. In the past decade, the burden of hepatitis A, B & C
has significantly increased compared to that of type D & E. In addition, in
emerging countries, around 90% of the children (below 10 years of age) are
infected with type A virus as stated by the WHO reports. These reports also
state that in 2016, around 71 million people were affected by the hepatitis C
and 257 million people were suffering from type B infection.
The
non-government and government organizations play a vital role in increasing
awareness of infectious diseases by conducting campaigns in order to deliver
correct knowledge about the symptoms, condition, and detection techniques.
Thereby, rendering a positive impact on the market growth owing to rising
demand for diagnostic tests. Furthermore, the adoption of molecular biology
techniques and other technologically advanced detection techniques are spurring
the market growth.
Browse
Details of Report @
https://www.grandviewresearch.com/industry-analysis/hepatitis-diagnostic-test-market
https://www.grandviewresearch.com/industry-analysis/hepatitis-diagnostic-test-market
Further key findings from the study suggest:
- The blood
tests segment dominate the market and is expected to exhibit the fastest
growth rate over the forecast period owing to their higher adoption as a
first line of diagnosis.
- The liver
function tests, sub type of blood test hold a significant share of the
market since these tests are the first line diagnostics and are
prerequisite for further analytical examinations required to performed for
confirmation of virus causing the disease
- North
America dominated with largest revenue share in 2016, owing to rising
prevalence, various government initiatives creating awareness regarding
rising incidences, and highly developed healthcare infrastructure
- Constant
rise in the new cases of hepatitis is observed in Asia Pacific. Thus, this
region is expected to witness a rapid growth during the forecast period.
- Some of the
major players competing include, but are not limited to Abbott
Laboratories; Danaher Corporation; F. Hoffmann Roche; DiaSorin S.p.A;
MedMira, Inc.; Siemens Ag, bioMeriuex SA; Hologic, Inc.; and Bio Rad
Laboratories.
- These
players dominate the market with their strong brand identity and extensive
geographic reach by their strategic initiatives such as mergers &
acquisition and partnership with other players.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment